Pershing Square USA (PSUS) holder keeps 10.1M shares after sale

Pershing Square USA (PSUS) reported that the Teacher Retirement System of Texas, a 10% owner, sold 6,205 shares at $40.06 each. The holder retains 10,143,795 shares. The sale occurred in an open market or private transaction.

Original reporting
Published Aug 19, 2026, 8:07 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 20, 2026, 2:45 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$PSUS
Neutral
high confidence
Mentioned
$PSUS
Relevance
4/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$PSUSNeutralLow
01

Why it matters

The disclosed sale is the first public report of this insider transaction; impact on price is expected to be negligible.

02

Market read

Primary disclosure of a minor insider sale; limited trading relevance.

03

What to watch

Potential upcoming fund rebalancing or distribution not disclosed.

Relevance 4/10Novelty 5/10Timing: same-day 2026-08-17

Background

Form 4 filing by a 10% owner of Pershing Square USA, a listed closed‑end fund.

Company-level read

Ticker impact

$PSUSNeutralHigh confidence
Context

Teacher Retirement System of Texas sold 6,205 PSUS shares at $40.06, retaining 10,143,795 shares.

Expected impact

little to no movement

Evidence & confidence

The transaction size ($249k) is trivial for a fund with >10M shares outstanding.

Market effects

None; the fund tracks a broad market strategy.

None; limited to fund shareholders.

Minimal

Counterpoint

The sale could signal insider concern, but size is too small to act on.

Key entities

  • Teacher Retirement System of Texas

    10% owner of PSUS filing a sale of 6,205 shares.

  • Pershing Square USA

    Closed‑end fund listed under ticker PSUS.

Related articles

$PSUSMedAI 9/10

Benzinga

Cyrille Bolloré, CEO of Bolloré SE, urged Universal Music Group to reject Bill Ackman’s $64 billion takeover bid, saying the price is “not there” and that the offer relies on company cash, according to Reuters. Bolloré controls 18.4% of UMG and Vivendi 13.4%, giving them blocking power. Ackman said Bolloré’s stake is key and proposed shifting UMG’s listing to NYSE.

$PSUSMedAI 9/10

Bill Ackman Progress Report One of the Largest Closed-End Fund Launches in History:

Bill Ackman’s Pershing Square USA closed-end fund raised $5 billion, priced at $50 per share, according to Renaissance Capital and other reports. The offering combined a registered public offering ($2.2 billion) and private placement ($2.8 billion). Reuters said it was among the largest recent IPOs for a closed-end fund. The vehicle is designed to provide “permanent capital” without redemption pressure.

$MRNAMed

WHO Recommends Two Additional Ebola Vaccines For Testing In DR Congo

The WHO recommended testing two Ebola vaccines, ChAdOx1 (Oxford/Serum Institute) and mRNA-1469 (Moderna), in the Tumaini trial in DRC. The trial, led by DRC's Institut National de Recherche Biomédicale, aims to evaluate vaccines against the Bundibugyo virus. Investments from CEPI have supported development. Results are expected in early 2027.